Lind-Holst Marie, Hartling Ulla Birgitte, Christensen Anne Estmann
Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
BMJ Case Rep. 2019 Aug 4;12(8):e229708. doi: 10.1136/bcr-2019-229708.
We report a 12-week-old boy presenting with incomplete refractory Kawasaki disease (KD) complicated with macrophage activation syndrome (MAS). The infant presented with cerebral irritability, pain, tachypnoea and vomiting for 10 days. He did not fulfil any of the classic diagnostic criteria for KD. Pericardial effusion on echocardiography in addition to severe dilatation of the coronary arteries in combination with leucocytosis and raised acute phase reactants led to the diagnosis of incomplete KD. Treatment with intravenous immunoglobulin and aspirin was initiated but without any response. The condition was subsequently refractory to additional treatment with infliximab and high-dose methylprednisolone. His condition worsened, fulfilling the criteria for MAS. High-dose anakinra was initiated, and remission of the inflammation was achieved.
我们报告了一名12周大的男孩,患有不完全性难治性川崎病(KD)并伴有巨噬细胞活化综合征(MAS)。该婴儿出现脑激惹、疼痛、呼吸急促和呕吐10天。他不符合任何KD的经典诊断标准。超声心动图显示有心包积液,同时冠状动脉严重扩张,伴有白细胞增多和急性期反应物升高,从而诊断为不完全性KD。开始静脉注射免疫球蛋白和阿司匹林治疗,但无任何反应。随后,英夫利昔单抗和大剂量甲泼尼龙的额外治疗也无效。他的病情恶化,符合MAS的标准。开始使用大剂量阿那白滞素,炎症得以缓解。
Pediatr Rheumatol Online J. 2014-7-11
Pediatr Rheumatol Online J. 2023-10-6
Indian Pediatr. 2014-2
Adv Exp Med Biol. 2024
Zhongguo Dang Dai Er Ke Za Zhi. 2023-6-15
Int J Physiol Pathophysiol Pharmacol. 2022-6-15
Curr Res Pharmacol Drug Discov. 2021
Front Pharmacol. 2017-3-28
Semin Arthritis Rheum. 2017-2
Hematol Oncol Clin North Am. 2015-10